Leading Japanese pharmaceutical firm Daiichi Sankyo Company Ltd, will acquire majority stake in India's largest drug maker Ranbaxy Laboratories Ltd. The companies have announced a binding share purchase and share subscription agreement (the "SPSSA") between Daiichi Sankyo, Ranbaxy and the Singh family, the largest and controlling shareholders of Ranbaxy.
Business Standard
http://www.business-standard.com/common/
storypage_c_online.php?leftnm=10&bKeyFlag=
IN&autono=39729
No comments:
Post a Comment